Switch to:
Also traded in: Brazil, Chile, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.09
NYSE:CVS's Cash to Debt is ranked lower than
93% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.36 vs. NYSE:CVS: 0.09 )
Ranked among companies with meaningful Cash to Debt only.
NYSE:CVS' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.14 Max: 1.14
Current: 0.09
0.04
1.14
Equity to Asset 0.38
NYSE:CVS's Equity to Asset is ranked higher than
58% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.32 vs. NYSE:CVS: 0.38 )
Ranked among companies with meaningful Equity to Asset only.
NYSE:CVS' s Equity to Asset Range Over the Past 10 Years
Min: 0.38  Med: 0.54 Max: 0.67
Current: 0.38
0.38
0.67
Interest Coverage 9.06
NYSE:CVS's Interest Coverage is ranked higher than
50% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.06 vs. NYSE:CVS: 9.06 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:CVS' s Interest Coverage Range Over the Past 10 Years
Min: 9.06  Med: 11.43 Max: 15.55
Current: 9.06
9.06
15.55
F-Score: 5
Z-Score: 3.63
M-Score: -2.70
WACC vs ROIC
7.60%
10.03%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 5.83
NYSE:CVS's Operating margin (%) is ranked higher than
67% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.14 vs. NYSE:CVS: 5.83 )
Ranked among companies with meaningful Operating margin (%) only.
NYSE:CVS' s Operating margin (%) Range Over the Past 10 Years
Min: 5.57  Med: 6.3 Max: 6.91
Current: 5.83
5.57
6.91
Net-margin (%) 2.96
NYSE:CVS's Net-margin (%) is ranked higher than
67% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.45 vs. NYSE:CVS: 2.96 )
Ranked among companies with meaningful Net-margin (%) only.
NYSE:CVS' s Net-margin (%) Range Over the Past 10 Years
Min: 2.96  Med: 3.44 Max: 3.76
Current: 2.96
2.96
3.76
ROE (%) 14.07
NYSE:CVS's ROE (%) is ranked higher than
62% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.51 vs. NYSE:CVS: 14.07 )
Ranked among companies with meaningful ROE (%) only.
NYSE:CVS' s ROE (%) Range Over the Past 10 Years
Min: 9.14  Med: 11.33 Max: 14.85
Current: 14.07
9.14
14.85
ROA (%) 5.50
NYSE:CVS's ROA (%) is ranked higher than
74% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.81 vs. NYSE:CVS: 5.50 )
Ranked among companies with meaningful ROA (%) only.
NYSE:CVS' s ROA (%) Range Over the Past 10 Years
Min: 5.46  Med: 6.16 Max: 7.64
Current: 5.5
5.46
7.64
ROC (Joel Greenblatt) (%) 65.19
NYSE:CVS's ROC (Joel Greenblatt) (%) is ranked lower than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 93.29 vs. NYSE:CVS: 65.19 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NYSE:CVS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 26.8  Med: 47.33 Max: 65.26
Current: 65.19
26.8
65.26
Revenue Growth (3Y)(%) 12.30
NYSE:CVS's Revenue Growth (3Y)(%) is ranked lower than
54% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.70 vs. NYSE:CVS: 12.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NYSE:CVS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 7.7  Med: 12.3 Max: 16
Current: 12.3
7.7
16
EBITDA Growth (3Y)(%) 15.10
NYSE:CVS's EBITDA Growth (3Y)(%) is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.50 vs. NYSE:CVS: 15.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NYSE:CVS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.5  Med: 14.2 Max: 43.7
Current: 15.1
2.5
43.7
EPS Growth (3Y)(%) 15.20
NYSE:CVS's EPS Growth (3Y)(%) is ranked higher than
65% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.10 vs. NYSE:CVS: 15.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NYSE:CVS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 1.7  Med: 15.2 Max: 112.8
Current: 15.2
1.7
112.8
» NYSE:CVS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

CVS Guru Trades in Q4 2015

Ray Dalio 83,137 sh (New)
George Soros 25,971 sh (New)
Paul Tudor Jones 8,633 sh (+232.04%)
Mairs and Power 3,819 sh (+70.04%)
Robert Olstein 64,000 sh (+42.22%)
RS Investment Management 788,185 sh (+10.33%)
PRIMECAP Management 3,545,070 sh (+4.00%)
Pioneer Investments 5,082,510 sh (+3.85%)
Manning & Napier Advisors, Inc 86,300 sh (+0.47%)
Richard Pzena 527,389 sh (+0.02%)
Vanguard Health Care Fund 3,084,020 sh (unchged)
Jeff Auxier 52,499 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Tom Gayner 247,000 sh (unchged)
Charles de Vaulx 840,664 sh (unchged)
Steven Romick Sold Out
Jim Simons Sold Out
John Burbank Sold Out
Louis Moore Bacon Sold Out
Joel Greenblatt Sold Out
Ken Fisher 122,308 sh (-0.40%)
NWQ Managers 760,638 sh (-2.91%)
Mario Gabelli 1,178,788 sh (-3.03%)
Barrow, Hanley, Mewhinney & Strauss 368,897 sh (-3.85%)
Jeremy Grantham 2,300,997 sh (-4.04%)
Ruane Cunniff 18,153 sh (-27.25%)
Scott Black 19,044 sh (-78.72%)
First Pacific Advisors 127,300 sh (-81.32%)
» More
Q1 2016

CVS Guru Trades in Q1 2016

Murray Stahl 3,090 sh (New)
Dodge & Cox 2,630 sh (New)
Jim Simons 195,105 sh (New)
Joel Greenblatt 220,252 sh (New)
Steven Cohen 115,300 sh (New)
Ken Fisher 142,324 sh (+16.37%)
George Soros 27,511 sh (+5.93%)
Pioneer Investments 5,363,313 sh (+5.52%)
Manning & Napier Advisors, Inc 87,090 sh (+0.92%)
Mario Gabelli 1,188,900 sh (+0.86%)
Jeremy Grantham 2,319,096 sh (+0.79%)
RS Investment Management 792,755 sh (+0.58%)
Richard Pzena 528,659 sh (+0.24%)
PRIMECAP Management 3,548,780 sh (+0.10%)
Tom Gayner 247,000 sh (unchged)
Robert Olstein 64,000 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Paul Tudor Jones 47,500 sh (unchged)
Paul Tudor Jones 50,200 sh (unchged)
Vanguard Health Care Fund Sold Out
Barrow, Hanley, Mewhinney & Strauss Sold Out
Ray Dalio Sold Out
Paul Tudor Jones Sold Out
Jeff Auxier 52,349 sh (-0.29%)
Signature Select Canadian Fund 70,053 sh (-3.31%)
Scott Black 18,149 sh (-4.70%)
NWQ Managers 707,549 sh (-6.98%)
Charles de Vaulx 778,764 sh (-7.36%)
Ruane Cunniff 15,981 sh (-11.96%)
First Pacific Advisors 106,140 sh (-16.62%)
Mairs and Power 3,069 sh (-19.64%)
» More
Q2 2016

CVS Guru Trades in Q2 2016

Jerome Dodson 234,000 sh (New)
Ray Dalio 149,700 sh (New)
John Buckingham 43,573 sh (New)
Louis Moore Bacon 2,679 sh (New)
Paul Tudor Jones 33,167 sh (New)
Jim Simons 3,842,105 sh (+1869.25%)
Joel Greenblatt 652,002 sh (+196.03%)
George Soros 41,175 sh (+49.67%)
Robert Olstein 91,000 sh (+42.19%)
RS Investment Management 897,935 sh (+13.27%)
Murray Stahl 3,397 sh (+9.94%)
First Pacific Advisors 114,190 sh (+7.58%)
Pioneer Investments 5,751,921 sh (+7.25%)
Richard Pzena 529,884 sh (+0.23%)
Tom Gayner 247,000 sh (unchged)
Jeff Auxier 52,349 sh (unchged)
Mairs and Power 3,069 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Dodge & Cox Sold Out
Steven Cohen Sold Out
PRIMECAP Management 3,527,170 sh (-0.61%)
Manning & Napier Advisors, Inc 86,530 sh (-0.64%)
Charles de Vaulx 753,827 sh (-3.20%)
Mario Gabelli 1,139,978 sh (-4.11%)
Scott Black 17,206 sh (-5.20%)
Ruane Cunniff 14,856 sh (-7.04%)
Ken Fisher 129,783 sh (-8.81%)
NWQ Managers 607,584 sh (-14.13%)
Jeremy Grantham 1,825,963 sh (-21.26%)
» More
Q3 2016

CVS Guru Trades in Q3 2016

David Dreman 9,185 sh (New)
Barrow, Hanley, Mewhinney & Strauss 9,100,036 sh (New)
Steven Cohen 82,162 sh (New)
John Paulson 122,200 sh (New)
Samuel Isaly 228,705 sh (New)
NWQ Managers 933,958 sh (+53.72%)
Scott Black 23,496 sh (+36.56%)
Robert Olstein 108,000 sh (+18.68%)
First Pacific Advisors 131,530 sh (+15.19%)
Jerome Dodson 256,000 sh (+9.40%)
Ken Fisher 132,741 sh (+2.28%)
Manning & Napier Advisors, Inc 87,010 sh (+0.55%)
Richard Pzena 529,858 sh (unchged)
Tom Gayner 247,000 sh (unchged)
George Soros 689,500 sh (unchged)
Ray Dalio Sold Out
Louis Moore Bacon Sold Out
George Soros Sold Out
Jeff Auxier 52,199 sh (-0.29%)
PRIMECAP Management 3,492,690 sh (-0.98%)
John Buckingham 42,964 sh (-1.40%)
Pioneer Investments 5,533,119 sh (-3.80%)
Mairs and Power 2,949 sh (-3.91%)
Murray Stahl 3,197 sh (-5.89%)
Mario Gabelli 1,065,457 sh (-6.54%)
Ruane Cunniff 13,801 sh (-7.10%)
Joel Greenblatt 440,659 sh (-32.41%)
Jeremy Grantham 1,144,482 sh (-37.32%)
Jim Simons 940,005 sh (-75.53%)
Paul Tudor Jones 6,831 sh (-79.40%)
» More
» Details

Insider Trades

Latest Guru Trades with CVS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:NAS:ESRX, NYSE:AET, NYSE:ANTM, NYSE:HUM, NYSE:CI, NYSE:UNH, NYSE:CNC, NYSE:WCG, NYSE:MOH, OTCPK:ODPVY, NAS:MGLN, NYSE:UAM, NAS:HIIQ, NAS:CNXR, OTCPK:OPRX, OTCPK:WCUI » details
Traded in other countries:CVSH34.Brazil, CVS.Chile, CVS.Germany, CVS.Mexico,
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

CVS Health Corp, formerly known as CVS Caremark Corporation was incorporated in the State of Delaware. The Company is an integrated pharmacy health care provider in the United States. It has three segments: Pharmacy Services, Retail Pharmacy and Corporate. The pharmacy services segment provides pharmacy benefit management services to their clients consisting of employers, insurance companies, unions, government employee groups, managed care organizations ("MCOs") and other sponsors of health benefit plans and individuals throughout the United States. The Company operates a network of mail service specialty pharmacies. There specialty pharmacies were comprised of 11 specialty mail order pharmacies located throughout the United States that are used for delivery of medications to individuals with chronic or genetic diseases and disorders. The retail pharmacy segment included 7,660 retail drugstores, of which 7,603 operated a pharmacy, their online retail pharmacy websites, CVS.com and Onofre.com.br, 17 onsite pharmacy stores and retail health care clinics. There corporate segment provides management and administrative services to support the operations of the company. The corporate Segment consists of certain aspects of executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments. Its customers include managed care organizations and government-funded health care commercial employers. It competes with other drugstore chains like Walgreens and Rite Aid, supermarkets, discount retailers (e.g., Wal-Mart and Target), independent pharmacies, restrictive pharmacy networks, membership clubs, Internet companies and retail health clinics, as well as other mail order pharmacies and PBMs. The Company's business is subject to federal and state laws and regulations that govern the purchase, sale and distribution of prescription drugs and related services, including administration and management of prescription drug benefits.

Guru Investment Theses on CVS Health Corp

Mario Gabelli Comments on CVS Health Corp - Nov 02, 2016

CVS Health Corp. (NYSE:CVS) (2.3%) (CVS – $88.99 – NYSE) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The stock declined in the quarter due to the significant political scrutiny around drug pricing. Efforts to regulate and control drug pricing could have an indirect impact on CVS’s revenues and earnings. However, we believe the company is a low cost provider who already works aggressively to improve health through the dispensing of low cost generic drugs, coordination of care, and efforts to improve adherence by patients.



From Mario Gabelli (Trades, Portfolio)'s Equity Income Fund 3rd quarter 2016 commentary.

Check out Mario Gabelli latest stock trades

Mario Gabelli Comments on CVS Health Corp - Feb 05, 2016

CVS Health Corp. (2.4%) (CVS – $97.77 – NYSE)(NYSE:CVS) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The company’s recent acquisitions of institutional pharmacy Omnicare and the pharmacies inside Target stores should add $0.15 to earnings in 2016 and further CVS’s dominance across the pharmacy channel. Same store sales should improve in 2016 now that the company has annualized its decision to stop selling tobacco, and that decision has helped them win over $11 billion in net new business for its pharmacy benefits management (PBM) division.

From Mario Gabelli (Trades, Portfolio)'s GAMCO Equity Income Fund fourth quarter 2015 commentary.

Check out Mario Gabelli latest stock trades

Mario Gabelli Comments on CVS Health Corp - Mar 12, 2015

CVS Health Corp. (0.9%) (CVS – $96.31 – NYSE) is a pharmacy innovation company helping people on their path to better health. Through their 7,800 retail pharmacies, more than 900 walk-in medical clinics, a leading pharmacy benefits manager with nearly 65 million plan members, and expanding specialty pharmacy services, CVS Health enables people, businesses and communities to manage health in more affordable, effective ways. Their unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.

From Mario Gabelli (Trades, Portfolio)’s Asset Fund Q4 2014 Commentary.

Check out Mario Gabelli latest stock trades

Top Ranked Articles about CVS Health Corp

Does the Increase in Volatility Signal a Dangerous Market Environment? Anxiety typically leads to knee-jerk reactions and excessive trading in their portfolios
Over the last several weeks stock price volatility has increased significantly above norms. All of a sudden it is not uncommon to see stock prices moving 5%, 10% or more in a single trading day. Interestingly, this volatility is occurring both to the upside and the downside. Common sense would suggest that the intrinsic value of a business cannot change by those orders of magnitude from one day to the next. Logic dictates that the market is either inaccurately pricing the stocks now or it was incorrectly pricing them the day before. Read more...
Robert Olstein Continues to Buy eBay, Walt Disney Stocks the investor bought for the past 2 quarters
Robert Olstein (Trades, Portfolio) is the chairman and chief investment officer of the Olstein Financial Alert Fund. In both the second and third quarters the guru bought shares in the following stocks: Read more...
Mario Gabelli Comments on CVS Health Corp Guru stock highlight
CVS Health Corp. (NYSE:CVS) (2.3%) (CVS – $88.99 – NYSE) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The stock declined in the quarter due to the significant political scrutiny around drug pricing. Efforts to regulate and control drug pricing could have an indirect impact on CVS’s revenues and earnings. However, we believe the company is a low cost provider who already works aggressively to improve health through the dispensing of low cost generic drugs, coordination of care, and efforts to improve adherence by patients. Read more...
Jim Simons Ups Stake in CVS Health Company is largest health care provider in US
During the second quarter, guru Jim Simons (Trades, Portfolio), the founder of the hedge fund Renaissance Technologies, added to his stake in CVS Health Corp. (CVS) by adding an additional 3,647,000 shares of the company to his portfolio. Simons now owns 3,842,105 shares of CVS Health Corp. Read more...
Ray Dalio's 5 Biggest 2nd-Quarter New Stock Buys Dalio bought Johnson & Johnson, CVS and more
Ray Dalio (Trades, Portfolio) manages the $150 billion Westport, Connecticut-based hedge fund Bridgewater Associates, the largest hedge fund firm in the world. The equity portfolio at Bridgewater has a total value of only $7.98 billion. According to filings disclosed Thursday, Dalio added 139 new positions to it in the second quarter. Read more...
Jerome Dodson Goes 3 for 3 in Second Quarter Dodson gains 3 new holdings, sells 3
Investor Jerome Dodson (Trades, Portfolio) of the Parnassus Fund gained three new holdings and sold out three holdings during the second quarter. Read more...
Stocks Manning & Napier Continues Buying Firm has been investing in these companies for the last 2 quarters
Manning & Napier Advisors Inc. was founded in April 1970 by Bill Manning and Bill Napier. It manages a portfolio composed of 325 stocks, several of which have been bought for the last two quarters. Read more...
Pioneer Investments Adds to Stake in CVS Company has 53 years of experience with over $150 billion in annual revenue
Pioneer Investments (Trades, Portfolio) was founded by Philip L. Carret in 1928. Carret started his own investment portfolio with $10,000. Over the course of the next 55 years, his initial investment grew to $8 million. Warren Buffett (Trades, Portfolio) once said that Carret had "the best long term investment record of anyone I know." Read more...
High Quality Guru Stocks Include TransDigm, Chipotle Stocks with high business predictability that gurus are buying
According to GuruFocus’ All-in-One Screener, the following stocks have a high business predictability rating and at least five gurus are shareholders in the companies. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 16.90
CVS's P/E(ttm) is ranked higher than
68% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.11 vs. CVS: 16.90 )
Ranked among companies with meaningful P/E(ttm) only.
CVS' s P/E(ttm) Range Over the Past 10 Years
Min: 10.58  Med: 18.33 Max: 27.17
Current: 16.9
10.58
27.17
Forward P/E 13.07
CVS's Forward P/E is ranked higher than
67% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.71 vs. CVS: 13.07 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 16.90
CVS's PE(NRI) is ranked higher than
73% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.17 vs. CVS: 16.90 )
Ranked among companies with meaningful PE(NRI) only.
CVS' s PE(NRI) Range Over the Past 10 Years
Min: 10.62  Med: 18.26 Max: 27.17
Current: 16.9
10.62
27.17
Price/Owner Earnings (ttm) 9.67
CVS's Price/Owner Earnings (ttm) is ranked lower than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.34 vs. CVS: 9.67 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
CVS' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 9.07  Med: 20.84 Max: 60.4
Current: 9.67
9.07
60.4
P/B 2.35
CVS's P/B is ranked higher than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.54 vs. CVS: 2.35 )
Ranked among companies with meaningful P/B only.
CVS' s P/B Range Over the Past 10 Years
Min: 1.01  Med: 1.79 Max: 3.37
Current: 2.35
1.01
3.37
P/S 0.50
CVS's P/S is ranked higher than
50% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.49 vs. CVS: 0.50 )
Ranked among companies with meaningful P/S only.
CVS' s P/S Range Over the Past 10 Years
Min: 0.4  Med: 0.61 Max: 0.89
Current: 0.5
0.4
0.89
PFCF 9.56
CVS's PFCF is ranked higher than
61% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.70 vs. CVS: 9.56 )
Ranked among companies with meaningful PFCF only.
CVS' s PFCF Range Over the Past 10 Years
Min: 8.96  Med: 21.4 Max: 211.81
Current: 9.56
8.96
211.81
POCF 7.50
CVS's POCF is ranked higher than
70% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.07 vs. CVS: 7.50 )
Ranked among companies with meaningful POCF only.
CVS' s POCF Range Over the Past 10 Years
Min: 6.72  Med: 13.06 Max: 19.27
Current: 7.5
6.72
19.27
EV-to-EBIT 11.51
CVS's EV-to-EBIT is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.11 vs. CVS: 11.51 )
Ranked among companies with meaningful EV-to-EBIT only.
CVS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.6  Med: 11.6 Max: 20.4
Current: 11.51
7.6
20.4
EV-to-EBITDA 9.15
CVS's EV-to-EBITDA is ranked lower than
59% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.52 vs. CVS: 9.15 )
Ranked among companies with meaningful EV-to-EBITDA only.
CVS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 9.4 Max: 16
Current: 9.15
6.2
16
PEG 1.21
CVS's PEG is ranked higher than
64% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.37 vs. CVS: 1.21 )
Ranked among companies with meaningful PEG only.
CVS' s PEG Range Over the Past 10 Years
Min: 0.56  Med: 1.37 Max: 2.48
Current: 1.21
0.56
2.48
Shiller P/E 24.07
CVS's Shiller P/E is ranked higher than
77% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.34 vs. CVS: 24.07 )
Ranked among companies with meaningful Shiller P/E only.
CVS' s Shiller P/E Range Over the Past 10 Years
Min: 17.19  Med: 25.97 Max: 39.08
Current: 24.07
17.19
39.08
Current Ratio 1.16
CVS's Current Ratio is ranked lower than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.26 vs. CVS: 1.16 )
Ranked among companies with meaningful Current Ratio only.
CVS' s Current Ratio Range Over the Past 10 Years
Min: 1.05  Med: 1.51 Max: 2.09
Current: 1.16
1.05
2.09
Quick Ratio 0.62
CVS's Quick Ratio is ranked lower than
74% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.26 vs. CVS: 0.62 )
Ranked among companies with meaningful Quick Ratio only.
CVS' s Quick Ratio Range Over the Past 10 Years
Min: 0.29  Med: 0.58 Max: 0.93
Current: 0.62
0.29
0.93
Days Inventory 35.31
CVS's Days Inventory is ranked lower than
70% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.97 vs. CVS: 35.31 )
Ranked among companies with meaningful Days Inventory only.
CVS' s Days Inventory Range Over the Past 10 Years
Min: 35.31  Med: 44.51 Max: 72.98
Current: 35.31
35.31
72.98
Days Sales Outstanding 28.80
CVS's Days Sales Outstanding is ranked higher than
58% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.62 vs. CVS: 28.80 )
Ranked among companies with meaningful Days Sales Outstanding only.
CVS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.77  Med: 21.26 Max: 28.8
Current: 28.8
18.77
28.8
Days Payable 19.20
CVS's Days Payable is ranked lower than
87% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 58.75 vs. CVS: 19.20 )
Ranked among companies with meaningful Days Payable only.
CVS' s Days Payable Range Over the Past 10 Years
Min: 16.69  Med: 19.86 Max: 28.69
Current: 19.2
16.69
28.69

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.16
CVS's Dividend Yield is ranked higher than
77% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.24 vs. CVS: 2.16 )
Ranked among companies with meaningful Dividend Yield only.
CVS' s Dividend Yield Range Over the Past 10 Years
Min: 0.42  Med: 1.13 Max: 2.19
Current: 2.16
0.42
2.19
Dividend Payout 0.35
CVS's Dividend Payout is ranked lower than
82% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.33 vs. CVS: 0.35 )
Ranked among companies with meaningful Dividend Payout only.
CVS' s Dividend Payout Range Over the Past 10 Years
Min: 0.08  Med: 0.15 Max: 1.4
Current: 0.35
0.08
1.4
Dividend Growth (3y) 29.10
CVS's Dividend Growth (3y) is ranked higher than
62% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.60 vs. CVS: 29.10 )
Ranked among companies with meaningful Dividend Growth (3y) only.
CVS' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -13.6  Med: 15.2 Max: 37
Current: 29.1
-13.6
37
Forward Dividend Yield 2.21
CVS's Forward Dividend Yield is ranked higher than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.21 vs. CVS: 2.21 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 8.64
CVS's Yield on cost (5-Year) is ranked higher than
74% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.52 vs. CVS: 8.64 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CVS' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.66  Med: 4.42 Max: 9.08
Current: 8.64
1.66
9.08
3-Year Average Share Buyback Ratio 3.70
CVS's 3-Year Average Share Buyback Ratio is ranked higher than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.20 vs. CVS: 3.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CVS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -22.5  Med: -0.3 Max: 4.7
Current: 3.7
-22.5
4.7

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.78
CVS's Price/Projected FCF is ranked higher than
77% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.96 vs. CVS: 0.78 )
Ranked among companies with meaningful Price/Projected FCF only.
CVS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.77  Med: 1.94 Max: 13.38
Current: 0.78
0.77
13.38
Price/DCF (Earnings Based) 1.03
CVS's Price/DCF (Earnings Based) is ranked higher than
78% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.27 vs. CVS: 1.03 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.81
CVS's Price/Median PS Value is ranked higher than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.07 vs. CVS: 0.81 )
Ranked among companies with meaningful Price/Median PS Value only.
CVS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.5  Med: 1.02 Max: 2.39
Current: 0.81
0.5
2.39
Price/Peter Lynch Fair Value 1.20
CVS's Price/Peter Lynch Fair Value is ranked higher than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.22 vs. CVS: 1.20 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CVS' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.63  Med: 1.54 Max: 6.09
Current: 1.2
0.63
6.09
Earnings Yield (Greenblatt) (%) 8.69
CVS's Earnings Yield (Greenblatt) (%) is ranked higher than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. CVS: 8.69 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CVS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.9  Med: 8.6 Max: 13.2
Current: 8.69
4.9
13.2
Forward Rate of Return (Yacktman) (%) 19.86
CVS's Forward Rate of Return (Yacktman) (%) is ranked higher than
65% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.58 vs. CVS: 19.86 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CVS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 11.3  Med: 17 Max: 24.2
Current: 19.86
11.3
24.2

More Statistics

Revenue (TTM) (Mil) $172,701
EPS (TTM) $ 4.67
Beta0.86
Short Percentage of Float1.58%
52-Week Range $69.30 - 106.67
Shares Outstanding (Mil)1,066.44

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 178,655 188,412 197,536
EPS ($) 5.61 6.00 6.38
EPS w/o NRI ($) 5.61 6.00 6.38
EPS Growth Rate
(3Y to 5Y Estimate)
14.15%
Dividends Per Share ($) 1.61 1.79 2.32
» More Articles for CVS

Headlines

Articles On GuruFocus.com
6 Worthy Dividend Stocks Down 10% or More Nov 22 2016 
Does the Increase in Volatility Signal a Dangerous Market Environment? Nov 11 2016 
CVS Not in the Pink After Earnings Call Nov 09 2016 
Robert Olstein Continues to Buy eBay, Walt Disney Nov 08 2016 
52-Week Company Lows Nov 03 2016 
Mario Gabelli Comments on CVS Health Corp Nov 02 2016 
Mario Gabelli's Equity Income Fund 3rd Quarter Commentary Nov 02 2016 
Upcoming November Earnings Releases for 6 Key Dividend Stocks Nov 02 2016 
Guru Pain Is Your Gain in McKesson Oct 31 2016 
52-Week Company Lows Oct 28 2016 

More From Other Websites
CVS Health and HHS Study Finds Proactive Pharmacy-based Outreach Helps Patients Access Needed... Dec 05 2016
CVS Health Achieves 100 Percent on 2017 Corporate Equality Index for Third Consecutive Year Dec 05 2016
CVS Pharmacy and MinuteClinic Encourage Families to Get Their Flu Shots During National Influenza... Dec 05 2016
CVS Health To Host 2016 Analyst Day For The Investment Community Dec 02 2016
Detroit's Rockbridge Growth Equity Announces Sale Of Triad Retail Media To Xaxis Dec 02 2016
Express Scripts Is One of the Most Powerful Players in Healthcare Nov 30 2016
Should You Buy 3M Co (MMM)? Nov 29 2016
OptumRx and CVS Pharmacy Partner to Expand Consumer Choice, Reduce Costs and Improve Health Outcomes Nov 29 2016
OptumRx and CVS Pharmacy Partner to Expand Consumer Choice, Reduce Costs and Improve Health Outcomes Nov 29 2016
What To Expect From Ulta Beauty Earnings On Thursday Nov 28 2016
CVS Health Corp (CVS): Are Hedge Funds Right About This Stock? Nov 25 2016
New Strong Sell Stocks for November 25th Nov 25 2016
Can't Wait For Black Friday? These Retail Stores Are Open On Thanksgiving Day Nov 23 2016
6 Worthy Dividend Stocks Down 10% or More Nov 22 2016
E.l.f., Ulta Beauty Shares Look Mighty Fine Ahead Of Black Friday Nov 22 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)